The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Allergic reactions (ARs) induced by FOLFOX4 treatment in colorectal cancer: A comparative analysis between Asian and Western patients (pts).
K. Sugihara
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult
A. Ohtsu
Employment or Leadership Position - Bayer (I)
Honoraria - Chugai Pharma; Novartis; Taiho Pharmaceutical
Y. Shimada
Honoraria - Chugai Pharma; Yakult
Research Funding - Daiichi Sankyo; Yakult
N. Mizunuma
No relevant relationships to disclose
P. Lee
No relevant relationships to disclose
A. De Gramont
Consultant or Advisory Role - Sanofi ; Yakult
Honoraria - Sanofi ; Yakult
R. M. Goldberg
Consultant or Advisory Role - Genentech; Lilly
Research Funding - Abbott Laboratories; Amgen; Bayer; Bristol-Myers Squibb; Genentech; Sanofi
M. L. Rothenberg
Consultant or Advisory Role - Sanofi
Research Funding - Sanofi
T. Andre
Honoraria - Baxter International; Sanofi ; Yakult
S. Brienza
Employment or Leadership Position - Debiopharm Group